恩典生命科技控股有限公司（已委任联席临时清盘人，仅作重组用途）（股票代码：02112）于2026年1月2日发布2025年12月股份变动月报表。报告期为2025年12月1日至12月31日，公司股本结构及发行股份保持稳定。
公司注册股本为3,000,000,000股普通股，面值每股HKD 0.01，注册股本总额为HKD 30,000,000。于本月末，公司已发行股份总数仍为1,500,000,000股，较上月底无任何变动；当月亦无股份回购、注销或库藏股增减，也无新增配发股份事项。
公司同时披露，当月并未有股份期权的授出、行使或失效，购股权计划余额维持不变。此外，公司确认已在报告期内遵守香港联交所《上市规则》及相关法律法规。该月报表由公司秘书陈坤签署。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.